HER2-positive Gastric Cancer
1 competing product in clinical development for HER2-positive Gastric Cancer.
Pipeline by Phase
Pre-clinical1
All Products (1)
| Product | Company | Stage | Status | Hype |
|---|---|---|---|---|
| Trastuzumab deruxtecan (T-DXd) | Daiichi Sankyo | Pre-clinical | Recruiting | 33 |